Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta 1,3 glucan is a polysaccharide composed of D-glucose monomers linked primarily by β-1,3-glycosidic bonds. It is found in the cell walls of fungi, yeast, some bacteria, and plants. It acts as an immunomodulator by binding to receptors on immune cells, stimulating innate immune responses and enhancing immune surveillance against tumors. Its structure and branching patterns affect its solubility and biological activity.
Binds to Dectin-1, CR3, and/or TLRs on immune cells, triggering downstream signaling pathways that activate the innate immune system, promote phagocytosis, and stimulate cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta 1,3 Glucan (β-1,3-glucan).